...
首页> 外文期刊>Saudi Pharmaceutical Journal >Bioassay-guided isolation of anti-hepatitis B virus flavonoid myricetin-3-O-rhamnoside along with quercetin from Guiera senegalensis leaves
【24h】

Bioassay-guided isolation of anti-hepatitis B virus flavonoid myricetin-3-O-rhamnoside along with quercetin from Guiera senegalensis leaves

机译:抗乙型肝炎病毒Flasconoidin-3-O-rhamnoside的生物测定引导分离与Guiera senegalensis叶片的槲皮素

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Recently, we have shown in vitro anti-hepatitis B virus (HBV) activity of G. senegalensis J.F. Gmel leaves, and Identified quercetin and other flavonoids by HPTLC. Here we report bioassay-directed fractionation of G. senegalensis leaves using column chromatography and isolation of two flavonoinds from the n -butanol fraction, their structure determination ( 1 H NMR, 13 C NMR and 2D-NMR) and assessment of antiviral activities (HBsAg and HBeAg assay) in HBV-reporter HepG2.2.2.15 cells. Further molecular docking was performed against HBV polymerase (Pol/RT) and capsid (Core) proteins as well as host-receptor sodium taurocholate co-transporting polypeptide (NTCP). The two isolated bioactive compounds were identified as quercetin and myricetin-3- O -rhamnoside. Quercetin significantly inhibited synthesis of HBsAg and HBeAg by about 60% and 62%, respectively as compared to myricetin-3- O -rhamnoside by 44% and 35%, respectively. Molecular docking of the two anti-HBV flavonoids revealed their higher binding affinities towards Pol/RT than Core and NTCP. In conclusion, this is the first report on anti-HBV active myricetin-3- O -rhamnoside along with quercetin isolated from G. senegalensis leaves. Their possible mode of anti-HBV activities are suggested through binding with viral Pol/RT and Core as well as host NTCP proteins.
机译:最近,我们已经显示出G. senegalensis J.F.Mbel叶的体外抗乙型肝炎病毒(HBV)活性,并通过HPTLC确定了槲皮素和其他黄酮类化合物。在这里,我们通过柱色谱法向G.塞内加仑的叶片报告生物测定的叶片分馏。从N-丁醇级分,其结构测定(1 H NMR,13 C NMR和2D-NMR)和评估抗病毒活性(HBsAg和HBEAG测定)在HBV记者HepG2.2.2.15细胞中。进一步的分子对接是针对HBV聚合酶(POL / RT)和衣壳(核心)蛋白以及宿主受体牛磺酸钠共传送多肽(NTCP)进行的。将两种分离的生物活性化合物鉴定为槲皮素和霉菌蛋白-3-O -Rhamnoside。槲皮素分别显着抑制HBsAg和HBeAg的合成约60%和62%,分别将44%和35%分别为44%和35%。两种抗HBV黄酮类化合物的分子对接揭示了它们比核和NTCP朝向POL / RT的更高的结合亲和力。总之,这是抗HBV活性霉素-3-O -RhamnoSide的第一个报告以及从G.塞内加伦斯叶中分离的槲皮素。通过与病毒热/ Rt和核心的结合和宿主NTCP蛋白质来提出它们可能的抗HBV活性模式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号